Kapusta Matthew C 4

4 · uniQure N.V. · Filed Sep 26, 2025

Insider Transaction Report

Form 4

Period: 2025-09-24

uniQure N.V.QURE

Kapusta Matthew C

DirectorCEO, Managing Director

Transactions

Sale
Ordinary Shares
2025-09-24$39.59/sh−51,316$2,031,600→ 826,454 total
Sale
Ordinary Shares
2025-09-24$41.69/sh−5,022$209,367→ 711,454 total
Exercise/Conversion
Ordinary Shares
2025-09-24$7.53/sh+51,316$386,409→ 702,770 total
Exercise/Conversion
Ordinary Shares
2025-09-24$6.22/sh+175,000$1,088,500→ 877,770 total
Sale
Ordinary Shares
2025-09-24$40.04/sh−60,000$2,402,400→ 766,454 total
Sale
Ordinary Shares
2025-09-24$40.68/sh−49,978$2,033,105→ 716,476 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-09-24−51,316→ 0 total
Exercise: $7.53Exp: 2026-09-29→ Ordinary Shares (51,316 underlying)
Sale
Ordinary Shares
2025-09-24$45.10/sh−60,000$2,706,000→ 651,454 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-09-24−175,000→ 0 total
Exercise: $6.22Exp: 2027-03-14→ Ordinary Shares (175,000 underlying)

Footnotes (9)

[F1]The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on January 28, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
[F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.20 to $40.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.42 to $41.42 The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.56 to $41.76. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.30. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F7]The Stock Option vested 25% on September 29, 2017 and 6.25% quarterly thereafter.
[F8]Adjusted to reflect the exercise and sale of 7,501 option shares under the Reporting Person's 10b5-1 plan on February 19, 2020.
[F9]The Stock Option vested 25% on March 14, 2018 and 6.25% quarterly thereafter.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT